Association between endometriosis and hyperprolactinemia in infertile women

Seddigheh Esmaeilzadeh, Parvaneh Mirabi, Zahra Basirat, Mahtab Zeinalzadeh, Soraya Khafri, Seddigheh Esmaeilzadeh, Parvaneh Mirabi, Zahra Basirat, Mahtab Zeinalzadeh, Soraya Khafri

Abstract

Background: The association of endometriosis with hyperprolactinemia is controversial.

Objective: The present study aimed to determine the frequency of endometriosis and association of prolactin with endometriosis in infertile women.

Materials and methods: 256 infertile women who underwent diagnostic laparoscopy for the evaluation of infertility, referred to Fatemezahra Infertility and Reproductive Health Research Center were included in a cross-sectional study. The presence of endometriosis was evaluated. To investigate the association of endometriosis with hyperprolactinemia, the patients whose infertility was not caused by endometriosis were included as control group. Serum prolactin (PRL) level was measured in both groups. The comparison of basal serum PRL levels between the two groups was performed, using independent t-test. One way ANOVA was used to determine PRL association with endometriosis stages.

Results: The frequency of endometriosis was found to be 29%. PRL levels were significantly higher in endometriosis group compared to control group (23.02±1.25 vs. 17.22±1.22 respectively, p=0.004). Statistically significant associations were found between staging of endometriosis and prolactin levels (p=0.01).

Conclusion: Hyperprolactinemia may be associated with endometriosis and its progression.

Keywords: Endometriosis; Hyperprolactinemia; Infertility; Laparoscopy.

Figures

Figure 1
Figure 1
Flow of participants through the study.

References

    1. Schrager S, Falleroni J, Edgoose J. Evaluation and treatment of endometriosis. Am Fam Physician. 2013;87:107–113.
    1. Moawad NS, Caplin A. Diagnosis, management, and long-term outcomes of rectovaginal endometriosis. Int J Womens Health. 2013;5:753–763.
    1. Ilangavan K, Kalu E. High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril. 2010;93:e10.
    1. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol. 2004;160:784–796.
    1. Lima AP, Moura MD, Rosa e Silva AA. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res. 2006;39:6.
    1. Speroff L. clinical gynecology endocrinology and infertility. 8th Ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
    1. Han Y, Zou SE, Long QQ, Zhang SF. The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with estrogen-progestogen add-back therapy in endometriosis patients of reproductive age. Int J Clin Exp Med. 2013;6:583–588.
    1. Pacchiarotti A, Frati P, Milazzo GN, Catalano A, Gentile V, Moscarini M. Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;172:62–64.
    1. Bokor A, Koszorus E, Brodszky V, Simoens S, Rigo J. [The impact of endometriosis on the quality of life in Hungary] Orv Hetil. 2013;154:1426–1434.
    1. Dong X, Liao X, Wang R, Zhang H. The impact of endometriosis on IVF/ICSI outcomes. Int J Clin Exp Pathol. 2013;6:1911–1918.
    1. Chrousos GP. Organization and integration of the endocrine system. Sleep Med Clin. 2007;2:125–145.
    1. Arumugam K. Serum prolactin levels in infertile patients with endometriosis. Malays J Pathol. 1991;13:43–45.
    1. Wang H, Gorpudolo N, Behr B. The role of prolactin- and endometriosis-associated infertility. Obstet Gynecol Surv. 2009;64:542–547.
    1. Machida T, Taga M, Minaguchi H. Prolactin secretion in endometriotic patients. Eur J Obstet Gynecol Reprod Biol. 1997;72:89–92.
    1. Gregoriou G, Bakas P, Vitoratos N, Papadias K, Goumas K, Chryssicopoulos A, et al. Evaluation of serum prolactin levels in patients with endometriosis and infertility. Gynecol Obstet Invest. 1999;48:48–51.
    1. Muse K WE, Jawal MJ. Prolactin hyperstimulation in response to thyrotropin-releasing hormone in patients with endometriosis. Fertil Steril. 2000;38:419–422.
    1. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–288.
    1. MAFaL S. clinical gynecology endocrinology and infertility. 8th Ed. Philadelphia: Lippincott Williams & Wilkins; 2011.
    1. Pauwels A, Schepens PJ, D'Hooghe T, Delbeke L, Dhont M, Brouwer A, et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum Reprod. 2001;16:2050–2055.
    1. Wang H, Gorpudolo N, Behr B. The Role of Prolactin and Endometriosis Associated Infertility. Obstet Gynecol Surv. 2009;54:5452–5547.
    1. Matalliotakis I PD, Vlassis G, Vavilis D, Neonaki M, Koumantakis E. PRL, TSH and their response to the TRH test in patients with endometriosis before, during, and after treatment with danazol. GynecolObstet Invest. 2000;42:183–186.
    1. Matorras RRF, PØrez C, Pijoan JI, Neyro JL, Rodríguez Es- cudero FJ. Infertile woman with and without endometriosis: a case control study of luteal phase and other infertility conditions. Acta Obstet Gynecol Scand. 2000;75:826–831.
    1. Haney AF, Handwerger S, Weinberg JB. Peritoneal fluid prolactin in infertile women with endometriosis: lack of evidence of secretory activity by endometrial implants. Fertil Steril. 1984;42:935–938.
    1. Hao M, Shi Y, Zhou C. [In vitro study of prolactin secretion by ectopic endometrial stromal cells] Zhonghua Fu Chan Ke Za Zhi. 2000;35:527–529.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit